When Avertus completes research and development on a medical device, mental health is an application that we will move into.
Depression is the fourth leading cause of disability worldwide and WHO projects that it will be second by 2020. Over 350,000,000 people worldwide suffer from depression and over 547,000,000 people worldwide suffer from anxiety. Electroencephalograms (EEG) have been used for mental health research to better understand the underlying brainwave patterns within the cortex. Current treatments for these illnesses include medication, psychotherapy and other forms of therapy which have varying success rates. A growing treatment segment for both anxiety and depression is biofeedback training using electroencephalograms.
A subject is fitted with an EEG machine and shown their brain waves on a screen. A depressive or anxious state of mind is induced and subjects are trained to bring their brain waves back under control. Biofeedback training has been shown to improve ADHD, anxiety, depression epilepsy, ASD, insomnia, drug addiction, schizophrenia, learning disabilities, dyslexia and dyscalculia. Because training is designed to teach subjects how to improve states of mind, they are unlikely to require follow up sessions.
The H10C dry electrode headset allows for the collection of clinical grade data from subjects with only a 30 second setup. Subjects are able to accurately visualize their brainwaves using our easy-to-use platform. Using our integrated cloud computing, physicians can access subject data in real time from remote locations making treatments like biofeedback more efficient in the future.